[go: up one dir, main page]

JPH05246875A - Agent for improving and treating diabetes - Google Patents

Agent for improving and treating diabetes

Info

Publication number
JPH05246875A
JPH05246875A JP4084730A JP8473092A JPH05246875A JP H05246875 A JPH05246875 A JP H05246875A JP 4084730 A JP4084730 A JP 4084730A JP 8473092 A JP8473092 A JP 8473092A JP H05246875 A JPH05246875 A JP H05246875A
Authority
JP
Japan
Prior art keywords
diabetes
improving
extract
asparagus
linearis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4084730A
Other languages
Japanese (ja)
Inventor
Kunihiko Kato
邦彦 加藤
Masatoshi Nakano
昌俊 中野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RUIBOSUTEII JAPAN KK
Original Assignee
RUIBOSUTEII JAPAN KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RUIBOSUTEII JAPAN KK filed Critical RUIBOSUTEII JAPAN KK
Priority to JP4084730A priority Critical patent/JPH05246875A/en
Publication of JPH05246875A publication Critical patent/JPH05246875A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To provide the diabetes-improving and treating agent containing the extract of Asparagus.linearis as an active ingredient, not causing adverse actions, capable of rapidly treating diabetes and having excellent safety. CONSTITUTION:The objective diabetes-improving and treating agent contains as an active ingredient an Asparagus.linearis extract which is obtained e.g. by adding a 50-1000 times volume of water to the leaves or stems of the Asparagus.linearis belonging to the genus Leguminosae, boiling the mixture, further boiling and extracting the mixture for 5-30min, and subsequently subjecting the treated mixture to a lyophilization treatment, etc. The agent is preferably drunk at a dose of 100-1500ml/day as a solution of 1-5g dried leaves/liter, when commonly administered as a beverage.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、マメ科に属するアスパ
ラサス・リネアリスの含有成分を有効成分とする糖尿病
改善治療剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a therapeutic agent for diabetes mellitus, which contains, as an active ingredient, a component of Aspalathus linealis belonging to the legume family.

【0002】[0002]

【従来の技術】近年、糖尿病は中年者とか高年者だけで
なく若年者にも尿中に糖(グルコース)がでる糖尿病者
が数多く表れ社会問題にもなってきている。糖尿病には
インシュリン投与によって治療効果の上がるインシュリ
ン依存型糖尿病とインシュリン投与で大きな効果の現れ
ない非インシュリン依存型糖尿病がある。
2. Description of the Related Art In recent years, diabetes has become a social problem because not only middle-aged and elderly people but also young people have many diabetics with glucose in their urine. Diabetes mellitus includes insulin-dependent diabetes mellitus whose therapeutic effect is improved by insulin administration and non-insulin-dependent diabetes mellitus in which insulin administration does not show a significant effect.

【0003】[0003]

【発明が解決しようとする課題】しかし、従来より、非
インシュリン依存型糖尿病は適当な治療法が無く、食事
療法あるいは運動療法がなされているが、患者の意志の
強さに左右されることが多く、効果が薄く糖尿病を安定
的に治療するのは難しい。
However, conventionally, non-insulin-dependent diabetes mellitus has no appropriate therapeutic method and diet or exercise therapy is used, but it depends on the strength of the patient's will. Many have little effect and it is difficult to treat diabetes stably.

【0004】また、日常強い意志を必要とせず日常通常
人と同様に飲食する事で、糖尿病を安定化する治療薬は
知られていない。
[0004] Further, there is no known therapeutic drug that stabilizes diabetes by eating and drinking in the same way as a normal person in daily life without requiring a strong will.

【0005】本発明は、前記課題を解決し、糖尿病を日
常経口的に摂取することで、有効な症状の改善治療剤を
提供することを目的とする。
An object of the present invention is to solve the above problems and to provide an effective therapeutic agent for improving symptom by ingesting diabetes daily orally.

【0006】そこで、本発明者らは、前記目的を達成す
るために鋭意研究を重ねた結果、マメ科に属するアスパ
ラサス・リネアリス抽出物が、糖尿病の患者に対し優れ
た効果を有し、かつ副作用がなく安全に改善できるとの
知見を得て本発明を完成した。
[0006] The inventors of the present invention have conducted extensive studies to achieve the above-mentioned object, and as a result, the Aspalathus linealis extract belonging to the legume family has an excellent effect on diabetic patients, and The present invention has been completed based on the finding that it can be safely improved without side effects.

【0007】本発明の有効成分は、アスパラサス・リネ
アリスの抽出液からなり、抽出法としては、アスパラサ
ス・リネアリスの葉または茎を水及び/または有機溶媒
で抽出し、該抽出液より抽出溶媒を留去する方法、また
はアスパラサス・リネアリスの葉または茎を粉砕するこ
とによって得ることができる。また、通常の日本茶、中
国茶、紅茶などの製法と同様に抽出してもよい。
The active ingredient of the present invention comprises an extract of Aspalathus linealis. As an extraction method, leaves or stems of Aspalathus linealis are extracted with water and / or an organic solvent, and the extraction solvent is extracted from the extract. Can be obtained by distilling off or by crushing leaves or stems of Aspalathus linealis. In addition, it may be extracted in the same manner as in the production method of ordinary Japanese tea, Chinese tea, black tea and the like.

【0008】水で抽出する場合には、アスパラサス・リ
ネアリスの50〜1000倍の水を加え、沸騰後、さら
に5〜30分程度沸騰抽出するのが好ましい。また、通
常の茶と同様抽出するときは、アスパラサス・リネアリ
スの乾燥葉の50〜500倍の80〜100度の湯で3
〜30分程度放置して抽出液を得る。
In the case of extraction with water, it is preferable to add 50 to 1000 times as much water as Aspalathus linealis, boil and then carry out boiling extraction for about 5 to 30 minutes. Also, when extracting in the same way as ordinary tea, use 3 to 50 times the hot water of 80 to 100 degrees, which is 50 to 500 times the dry leaves of Aspalathus linearis.
Leave for about 30 minutes to obtain an extract.

【0009】有機溶媒の具体例としては、メタノール、
エタノール、アセトン等が挙げられ、抽出にあたっては
温時抽出等慣用手段を用いることができる。また、抽出
液の分離も、デカンテーションや遠心分離等の慣用手段
を用いることができる。
Specific examples of the organic solvent include methanol,
Ethanol, acetone and the like can be mentioned, and conventional means such as warm extraction can be used for extraction. Further, for the separation of the extract, conventional means such as decantation or centrifugation can be used.

【0010】抽出溶媒の留去も凍結乾燥等の慣用手段を
用いることができる。また、アスパラサス・リネアリス
そのものを粉砕し、粉末化して用いることもできる。
A conventional means such as freeze-drying can be used for distilling off the extraction solvent. Also, Aspalathus linealis itself can be crushed and powdered for use.

【0011】本発明は、混合してそのまま溶液、粉末顆
粒、錠剤、乳剤、ゼリー状など任意の形態で単独投与、
または他の飲食物に混合して飲食することもできる。
According to the present invention, a mixture is directly administered in any form such as a solution, powder granules, tablets, emulsions or jellies.
Alternatively, it can be mixed with other foods and drinks.

【0012】投与量は、対象となる疾患の種類、程度に
より異なるが、飲料として常用する場合には、1〜5g
乾燥葉/1溶液を100ml〜1500ml/日飲食す
るのが好ましい。
The dose varies depending on the type and degree of the target disease, but in the case of regular use as a drink, 1 to 5 g
It is preferable to eat and drink 100 ml to 1500 ml / day of the dried leaf / 1 solution.

【0013】アスパラサス・リネアリスは、ラットに対
する急性毒性試験で死亡例は皆無であり、生化学血液検
査および病理組織学的検査においても異常が認められな
かった。
[0013] Aspalathus linealis showed no death in an acute toxicity test in rats, and no abnormality was observed in biochemical blood tests and histopathological tests.

【0014】[0014]

【効果】本発明は、ヒトを含む哺乳動物の糖尿病の疾患
を副作用無く、迅速に改善治療することができる。
The present invention can rapidly improve and treat diabetic diseases of mammals including humans without side effects.

【0015】[0015]

【実施例】【Example】

製造例 採取したアスパラサス・リネアリスの葉(茎つき)を、
5mm長に切断後、ローリング、酵素醗酵、天日乾燥の
工程を経て乾燥葉とする。乾燥葉4gを水1.5リット
ルで15分間沸騰させ抽出液を得た。
Production example Collected Aspalathus linealis leaves (with stem)
After cutting to a length of 5 mm, dried leaves are subjected to the steps of rolling, enzyme fermentation, and sun drying. 4 g of dried leaves were boiled with 1.5 liters of water for 15 minutes to obtain an extract.

【0016】実施例1 製造例で得た抽出液を表1に示した患者に1日200m
Lから1000mL飲ませ、症状の改善を調べた。結果
を表1に示す。
Example 1 The extract obtained in the production example was applied to the patients shown in Table 1 at 200 m per day.
1000 mL of L was given to examine the improvement of symptoms. The results are shown in Table 1.

【表1】 [Table 1]

【0017】アスパラサス・リネアリスの化学分析結果
は下記の通りである。 鉄 23.40mg/100g カルシウム 187.00mg/100g カリウム 398.00mg/100g マグネシウム 207.00mg/100g 銅 2.25ppm 亜鉛 6.74ppm セレン 0.13ppm ビタミンE 17.00mg/100g たんぱく質 8.00% フラボノイド 41.00mg/100g 抗酸化能・SOD様力価 69,000unit/g 酸不溶性蛋白成分 150mg/100g 香気成分 100mg/100g 糖含有化合物 690mg/100g
The results of chemical analysis of Aspalathus linealis are as follows. Iron 23.40 mg / 100 g Calcium 187.00 mg / 100 g Potassium 398.00 mg / 100 g Magnesium 207.00 mg / 100 g Copper 2.25 ppm Zinc 6.74 ppm Selenium 0.13 ppm Vitamin E 17.00 mg / 100 g Protein 8.00% Flavonoids 41 0.000 mg / 100 g Antioxidant / SOD-like potency 69,000 unit / g Acid-insoluble protein component 150 mg / 100 g Aroma component 100 mg / 100 g Sugar-containing compound 690 mg / 100 g

【0018】また香気成分として、カルボニル化合物
(15%)、カロチノイド分解物(17%)、炭素数2
〜12の有機酸(22%)、フェノール化合物(13
%)、芳香族含酸素化合物(7%)、芳香族炭化水素
(5.5%)、テルペノイド(4%)などを含有する。
なお、酸不溶性蛋白質とは比較的分子量の大きな蛋白成
分である。
As aroma components, carbonyl compound (15%), carotenoid decomposition product (17%), carbon number 2
~ 12 organic acids (22%), phenolic compounds (13
%), Aromatic oxygen-containing compounds (7%), aromatic hydrocarbons (5.5%), terpenoids (4%) and the like.
The acid-insoluble protein is a protein component having a relatively large molecular weight.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 アスパラサス・リネアリス抽出物を有効
成分とする糖尿病改善治療剤
1. A therapeutic agent for diabetes mellitus comprising an Aspalathus linealis extract as an active ingredient.
JP4084730A 1992-03-06 1992-03-06 Agent for improving and treating diabetes Pending JPH05246875A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4084730A JPH05246875A (en) 1992-03-06 1992-03-06 Agent for improving and treating diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4084730A JPH05246875A (en) 1992-03-06 1992-03-06 Agent for improving and treating diabetes

Publications (1)

Publication Number Publication Date
JPH05246875A true JPH05246875A (en) 1993-09-24

Family

ID=13838812

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4084730A Pending JPH05246875A (en) 1992-03-06 1992-03-06 Agent for improving and treating diabetes

Country Status (1)

Country Link
JP (1) JPH05246875A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008156264A (en) * 2006-12-22 2008-07-10 Daishoo:Kk Postprandial hyperglycemia and blood uric acid lowering effect of rooibos tea
WO2008110551A1 (en) 2007-03-12 2008-09-18 Zadec Aps An anti-diabetic extract of rooibos

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008156264A (en) * 2006-12-22 2008-07-10 Daishoo:Kk Postprandial hyperglycemia and blood uric acid lowering effect of rooibos tea
WO2008110551A1 (en) 2007-03-12 2008-09-18 Zadec Aps An anti-diabetic extract of rooibos
JP2010520913A (en) * 2007-03-12 2010-06-17 サズセ アーペーエス Rooibos anti-diabetic extract
EP2368560A1 (en) * 2007-03-12 2011-09-28 Zadec ApS An anti-diabetic extract of rooibos
US8877717B2 (en) 2007-03-12 2014-11-04 Zadec Aps Anti-diabetic extract of rooibos

Similar Documents

Publication Publication Date Title
KR20160007728A (en) Method for manufacturing garlic skin extract and food composition for preventing and alleviating diabetes prepared using the same
JP2019502721A (en) Hangover composition
CN103584091B (en) A kind of guarantor with raising immunity, hypolipemic function builds food and preparation method thereof
JPH05246866A (en) Agent for stimulating cerebral metabolism and for improving cerebral function
JP3334725B2 (en) Accelerator for reducing alcohol in the body, its metabolites and oral freshener
JPH06199695A (en) Agent for amelioration and treatment of diabetes
KR100377313B1 (en) Method Of Fabricating Green tea Extractive
JP2895298B2 (en) Active oxygen scavenging / removal agent
JPH0840923A (en) Nutrient-supplying agent
JPH05246875A (en) Agent for improving and treating diabetes
JP2004352626A (en) Anti-cholesterol agent containing plant-derived components
JP3167777B2 (en) Antiviral, antibacterial and bactericide
JP2724524B2 (en) Constipation improvement / treatment agent
JPH04300836A (en) Hepatic dysfunction preventive agent and functional food having preventive action on hepatic dysfunction
KR100337472B1 (en) Health food beverage composition containing prickly pear extract
JP3167776B2 (en) Anticancer / anticancer agent
JP3435415B2 (en) Foods with antihyperlipidemic function
CN108077485A (en) A kind of blue or green money willow herbal tea and preparation method thereof
JPH05246873A (en) Agent for improving hepatic function and for preventing hangover
JP3154544B2 (en) Inflammatory disease improving therapeutic agent
JPH05246871A (en) Agent for improving and treating anemia
JPH05271057A (en) Improving and curing agent for rheumatism
JPH05271058A (en) Improving and curing agent for cataract
CN107334913B (en) Black garlic extract and preparation method and application thereof
CA2291974C (en) Composition comprising panax pseudo ginseng and eucommiae ulmoides